"
Team:SupBiotech-Paris/Concept2Fr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 10: | Line 10: | ||
http://www.editeurjavascript.com | http://www.editeurjavascript.com | ||
*/ | */ | ||
| - | window.open('https://2009.igem.org/Image:Phage_lambda.pdf','_blank','toolbar=0, location=1, directories=0, status=0, scrollbars=1, resizable=1, copyhistory=0, menuBar=0, width=500, height=500, left= | + | window.open('https://2009.igem.org/Image:Phage_lambda.pdf','_blank','toolbar=0, location=1, directories=0, status=0, scrollbars=1, resizable=1, copyhistory=0, menuBar=0, width=500, height=500, left=100, top=10'); |
</SCRIPT> | </SCRIPT> | ||
<!-- FIN DU SCRIPT --><noscript><a href="http://www.editeurjavascript.com/countus/">compteur live</a></noscript> | <!-- FIN DU SCRIPT --><noscript><a href="http://www.editeurjavascript.com/countus/">compteur live</a></noscript> | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 14:53, 22 September 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Action antitumorale Modeling du traitement Conclusion
Ressources
BioBricks Matériel & Méthode Bibliographie
Ethique & sûreté
